[1]
Likhariya, M.K. et al. 2026. Formulation And Optimization Of Extended-Release Matrix Tablets Of Nateglinide. Adolescência e Saúde. 21, 4s (Jul. 2026), 776–785. DOI:https://doi.org/10.67440/ahj.v21i4s.1218.